Ignite Creation Date:
2025-12-24 @ 9:55 PM
Ignite Modification Date:
2025-12-25 @ 7:34 PM
Study NCT ID:
NCT01844232
Status:
COMPLETED
Last Update Posted:
2022-04-25
First Post:
2013-04-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity
Sponsor:
RVL Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04
Start Date Type:
None
Primary Completion Date:
2014-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-24
First Submit QC Date:
None
Study First Post Date:
2013-05-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-01-13
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-04-21
Last Update Post Date:
2022-04-25
Last Update Post Date Type:
ACTUAL